BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wakabayashi T, Shinoda M, Obara H, Kitago M, Yagi H, Abe Y, Matsubara K, Yamada Y, Oshima G, Hirukawa K, Mizota T, Hibi T, Itano O, Hoshino K, Kuroda T, Kitagawa Y. Decreased Incidence of Acute Cellular Rejection in Low-Muscle-Mass Recipients After Living-donor Liver Transplantation. Transplantation Proceedings 2018;50:3626-34. [DOI: 10.1016/j.transproceed.2018.06.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Lichvar A, Chan C, Choi D. Evaluating the Incidence and Risk Factors for Acute Cellular Rejection in a Steroid Sparing Liver Transplant Center. Ann Pharmacother 2022;:10600280221120059. [PMID: 36004388 DOI: 10.1177/10600280221120059] [Reference Citation Analysis]
2 Lerut J, Iesari S. Immunosuppression and liver transplantation. Engineering 2022. [DOI: 10.1016/j.eng.2022.07.007] [Reference Citation Analysis]
3 Hey P, Hoermann R, Gow P, Hanrahan TP, Testro AG, Apostolov R, Sinclair M. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients. World J Transplant 2022; 12(6): 120-130 [DOI: 10.5500/wjt.v12.i6.120] [Reference Citation Analysis]
4 Lerut JP, Gondolesi GE. Immunosuppression in liver and intestinal transplantation. Best Pract Res Clin Gastroenterol 2021;54-55:101767. [PMID: 34874848 DOI: 10.1016/j.bpg.2021.101767] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Takeda M, Sakamoto S, Uchida H, Shimizu S, Yanagi Y, Fukuda A, Nosaka S, Kasahara M. Impact of sarcopenia in infants with liver transplantation for biliary atresia. Pediatr Transplant 2021;25:e13950. [PMID: 33326674 DOI: 10.1111/petr.13950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Pravisani R, Hidaka M, Baccarani U, Hanada M, Hara T, Kugiyama T, Hamada T, Eguchi S. Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation. Liver Transpl 2020;26:1200-1. [PMID: 32291911 DOI: 10.1002/lt.25777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tsukagoshi M, Yokobori T, Yajima T, Maeno T, Shimizu K, Mogi A, Araki K, Harimoto N, Shirabe K, Kaira K. Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer. Medicine (Baltimore) 2020;99:e19059. [PMID: 32049805 DOI: 10.1097/MD.0000000000019059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
8 Takemura Y, Hibi T, Shinoda M, Obara H, Minagawa T, Kitago M, Yagi H, Abe Y, Matsubara K, Oshima G, Hori S, Hoshino K, Yamada Y, Itano O, Takano Y, Kuroda T, Hasegawa N, Kitagawa Y. Methicillin-resistant Staphylococcus aureus carriers are vulnerable to bloodstream infection after living donor liver transplantation. Clin Transplant 2019;33:e13753. [PMID: 31692105 DOI: 10.1111/ctr.13753] [Reference Citation Analysis]